Navigation Links
Dysport Added as a Procedure on AmericanHealthandBeauty.com: Let the Wrinkle Wars Begin
Date:6/19/2009

After recent FDA approval and a surge in interest from readers, AmericanHealthandBeauty.com has added Dysport, formerly known as Reloxin, as a procedure on their website.

Houston, TX (PRWEB) June 19, 2009 -- Dysport(TM), a new cosmetic injectable used for treatment of fine lines and wrinkles on the face, has recently gained FDA approval and is expected to start hitting physicians' shelves in July, 2009. To spread the word, AmericanHealthandBeauty.com has added Dysport to their list of cosmetic and aesthetic procedures. Doctors and medical spas offering this treatment have the opportunity to advertise the procedure now, staying ahead of the curve.

Dysport uses a purified form of botulinum toxin type A, which when used in the appropriate dosage, temporarily paralyzes key muscles in the face, allowing them to relax, greatly reducing the appearance of wrinkles and fine lines. Dysport is the first FDA approved drug of its type to compete with BOTOX(TM), which also uses the botulinum toxin. Jeffrey Adelglass, M.D., F.A.C.S., a cosmetic physician and Medical Director of SKINTASTIC Medical and Surgical Rejuvenation Center of Plano, who is currently one of the largest injectors of BOTOX in North Texas and the U.S., says, "the major benefits of Dysport to the cosmetic patient will be that there are fewer injections needed, and results hopefully will last a little longer. Also, because of the spread, many patients find it takes action sooner, usually within 1-2 days, compared to BOTOX which typically takes 3-5 days." However, Dr. Adelglass also stresses that knowing your cosmetic injector has the right credentials and training will be very important. "It is suggested that Dysport results might last up to a month or even two beyond that of BOTOX -- which could be a real bonus as long as the outcome is what you wanted; if not, you'll have that much longer to live with the results." He also stated that Dysport is "great for men with large foreheads." Dr. Adelglass, M.D., F.A.C.S. serves on the medical advisory board for Dysport, and on the National Education Foundation for Allergan, instructing other cosmetic physicians to safely administer Botox Cosmetic.

"We're already seeing a quick rise in patients asking about Dysport, so it became clear that we needed to include it on the site," says Keith Veseleny, editor of AmericanHealthandBeauty.com. "We're really excited to see what happens in July when Dysport comes out. If the inquiries we're getting are any indication, this will be one of the U.S.'s most popular procedures."

Through American Health and Beauty's aesthetic search portal, readers have access to one of the largest directories of aesthetic providers and medical spas in the world, comprehensive information about each doctor, and accurate listings of each provider's medical offerings, in addition to current news and events in the Aesthetic and Medical Spa industry.

American Health and Beauty(TM) is a national online health and beauty magazine devoted to providing information and resources about aesthetic and cosmetic procedures, including Vaser, SmartLipo, Thermage, VelaShape, Fraxel, BOTOX and just about every other cosmetic or aesthetic procedure available today.

Physicians and providers of Dysport interested in advertising with AmericanHealthandBeauty.com can request a free, no commitment trial period by calling 713-354-9961 X2 or through the website, www.americanhealthandbeauty.com

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2551374.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble
2. Autism Course Added to HealthForumOnline's Continuing Education (CE) Website for Mental Health Professionals & Nurses
3. Allied World U.S. Announces Strategic Response(SM) - Complimentary Service Added to General Liability Lead Umbrella Product
4. Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insulin, With Lower Risk of Hypoglycemia and Without Weight Gain: Data Presented at ADA 2009
5. Versus Technology, Inc. Announces Spring 09 Release for Added Workflow Automation
6. Cleanose Personal Air Filters Offer Added Protection From Inhaled Viruses/ Swine Flu/ H1N1 and Other Inhaled Dangers
7. New Partnerships Added to World Federation of Hemophilia Twinning Program
8. Omega-3s of No Added Benefit to Heart Attack Patients
9. HIPAA Amendments Contained in President Obamas Stimulus Bill Among New Sessions Added to HCCAs 2009 Compliance Institute
10. SXC Health Solutions Added to S&P/TSX Composite Index
11. Younger Women With Breast Cancer Face Added Peril
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... NY (PRWEB) , ... January 20, 2017 , ... ... VW+ 001 and its sugar-free alternative VW+ 002. The drinks have been produced ... with optimal conditions to perform during your workout. , After a successful launch ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... ... 2017 , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection ... is the creation of published author, Gene Gaapf, a retired truck driver, and a ... have been writing since high school and have many different titles,” Gaapf mentions about ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... an On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician ... on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... BOSTON , Jan. 19, 2017  Stealth BioTherapeutics ... therapeutics to treat mitochondrial dysfunction, today announced new additions ... , M.D., as Chief Medical Officer, and Daniel ... Stealth announced that Jim Carr , Pharm.D. has ... "We are pleased to welcome Doug and Daniel ...
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: